locally advanced or metastatic ER+/HER2- breast cancer
Conditions
Interventions
None listed
Sponsors
Pfizer Inc.
Eligibility
Sex/Gender
All
Age
18 Years to 64 Years
Countries
Belgium
Outcome results
None listed